Supersaturable self-microemulsifying drug delivery system enhances dissolution and bioavailability of telmisartan

References

• Augustijns P, Brewster ME. 2012. Supersaturating drug delivery systems: fast is not necessarily good enough. J Pharm Sci. 101(1):7–9.
   PubMed Web of Science ®Google Scholar
• Bolko K, Zvonar A, Gašperlin M. 2014. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility. Drug Dev Ind Pharm. 40(1):102–109.
   PubMed Web of Science ®Google Scholar
• Borhade V, Nair H, Hegde D. 2008. Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech. 9(1):13–21.
   PubMed Web of Science ®Google Scholar
• Brouwers J, Brewster ME, Augustijns P. 2009. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 98(8):2549–2572.
   PubMed Web of Science ®Google Scholar
• Buya AB, Ucakar B, Beloqui A, Memvanga PB, Préat V. 2020. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDSs) for senicapoc. Int J Pharm. 580:119180.
   PubMed Web of Science ®Google Scholar
• Chae JS, Chae BR, Shin DJ, Goo YT, Lee ES, Yoon HY, Kim CH, Choi YW. 2018. Tablet formulation of a polymeric solid dispersion containing amorphous alkalinized telmisartan. AAPS PharmSciTech. 19(7):2990–2999.
   PubMed Web of Science ®Google Scholar
• Chella N, Narra N, Rama Rao T. 2014. 2014. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan. J Drug Deliv. 2014:1–10.
   Google Scholar
• Chen Z-Q, Liu Y, Zhao JH, Wang L, Feng NP. 2012. Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system. Int J Nanomedicine. 7:1115–1125.
   PubMed Web of Science ®Google Scholar
• Dixit AR, Rajput SJ, Patel SG. 2010. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech. 11(1):314–321.
   PubMed Web of Science ®Google Scholar
• Gao P, Akrami A, Alvarez F, Hu J, Li L, Ma C, Surapaneni S. 2009. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption . J Pharm Sci. 98(2):516–528.
   PubMed Web of Science ®Google Scholar
• Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. 2004. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm. 30(2):221–229.
   PubMed Web of Science ®Google Scholar
• Gao P, Rush BD, Pfund WP, Huang T, Bauer JM, Morozowich W, Kuo MS, Hageman MJ. 2003. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 92(12):2386–2398.
   PubMed Web of Science ®Google Scholar
• Jaiswal P, Aggarwal G, Harikumar SL, Singh K. 2014. Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan. Int J Pharma Investig. 4(4):195.
   PubMedGoogle Scholar
• Jantratid E, Janssen N, Reppas C, Dressman JB. 2008. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res. 25(7):1663–1676.
   PubMed Web of Science ®Google Scholar
• Kanaujia P, Poovizhi P, Ng W, Tan R. 2015. Amorphous formulations for dissolution and bioavailability enhancement of poorly soluble APIs. Powder Tech. 285:2–15.
   Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. 2004. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 274(1-2):65–73.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Sugano K, da Costa Mathews C, Wong JW, Jones KL, Masaoka Y, Sakuma S, Yamashita S. 2012. Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development. Pharm Res. 29(6):1485–1494.
   PubMed Web of Science ®Google Scholar
• Kausalya J, Suresh K, Padmapriya S, Rupenagunta A, Senthilnathan B. 2011. Solubility and dissolution enhancement profile of telmisartan using various techniques. Int J Pharm Tech Res. 3(3):1737–1749.
   Google Scholar
• Khan KA. 1975. The concept of dissolution efficiency. J Pharm Pharmacol. 27(1):48–49.
   PubMed Web of Science ®Google Scholar
• Kyatanwar AU, Jadhav KR, Kadam VJ. 2010. Self micro-emulsifying drug delivery system (SMEDDS). J Pharm Res. 3(2):75–83.
   Google Scholar
• Lee DR, Ho MJ, Jung HJ, Cho HR, Park JS, Yoon SH, Choi YS, Choi YW, Oh CH, Kang MJ. 2016. Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system. Int J Nanomedicine. 11:1109.
   PubMed Web of Science ®Google Scholar
• Lee DH, Yeom DW, Song YS, Cho HR, Choi YS, Kang MJ, Choi YW. 2015. Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS). Int J Pharm. 478(1):341–347.
   PubMed Web of Science ®Google Scholar
• Mohsin K, Long MA, Pouton CW. 2009. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci. 98(10):3582–3595.
   PubMed Web of Science ®Google Scholar
• O'driscoll C, Griffin B. 2008. Biopharmaceutical challenges associated with drugs with low aqueous solubility-the potential impact of lipid-based formulations. Adv Drug Deliv Rev. 60(6):617–624.
   PubMed Web of Science ®Google Scholar
• Patel D, Sawant KK. 2009. Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs. Curr Drug Deliv. 6(4):419–424.
   PubMedGoogle Scholar
• Pouton CW. 2006. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 29(3-4):278–287.
   PubMed Web of Science ®Google Scholar
• Shen H, Zhong M. 2006. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin . J Pharm Pharmacol. 58(9):1183–1191.
   PubMed Web of Science ®Google Scholar
• Singh AK, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar RK, Mukherjee R. 2009. Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech. 10(3):906–916.
   PubMed Web of Science ®Google Scholar
• Son HY, Chae BR, Choi JY, Shin DJ, Goo YT, Lee ES, Kang TH, Kim CH, Yoon HY, Choi YW. 2018. Optimization of self-microemulsifying drug delivery system for phospholipid complex of telmisartan using D-optimal mixture design. PLoS One. 13(12):e0208339.
   PubMed Web of Science ®Google Scholar
• Song WH, Park JH, Yeom DW, Ahn BK, Lee KM, Lee SG, Woo HS, Choi YW. 2013. Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation. Arch Pharm Res. 36(1):69–78.
   PubMed Web of Science ®Google Scholar
• Tran PHL, Tran HTT, Lee BJ. 2008. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J Control Release. 129(1):59–65.
   PubMed Web of Science ®Google Scholar
• Tran PHL, Tran TTD, Park JB, Min DH, Choi HG, Han HK, Rhee YS, Lee BJ. 2011. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage. Int J Pharm. 414(1-2):48–55.
   PubMed Web of Science ®Google Scholar
• Warren DB, Benameur H, Porter CJ, Pouton CW. 2010. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility. J Drug Target. 18(10):704–731.
   PubMed Web of Science ®Google Scholar
• Wienen W, Entzeroth M, Meel JCA, Stangier J, Busch U, Ebner T, Schmid J, Lehmann H, Matzek K, Kempthorne-Rawson J, et al. 2000. A review on telmisartan: a novel, long‐acting angiotensin II‐receptor antagonist. Cardiovasc Drug Rev. 18(2):127–154.
   Google Scholar
• Xu S, Dai WG. 2013. Drug precipitation inhibitors in supersaturable formulations. Int J Pharm. 453(1):36–43.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Fukunishi A, Higashino H, Kataoka M, Wada K. 2017. Design of supersaturable formulation of telmisartan with pH modifier: in vitro study on dissolution and precipitation. J Pharm Investig. 47(2):163–171.
   Google Scholar
• Yang L, Shao Y, Han HK. 2014. Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex. Int J Pharm. 471(1-2):258–263.
   PubMed Web of Science ®Google Scholar
• Yeom DW, Chae BR, Son HY, Kim JH, Chae JS, Song SH, Oh D, Choi YW. 2017. Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system. Int J Nanomedicine. 12:3533–3545.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Diener H-C, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, et al.; PRoFESS Study Group. 2008. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 359(12):1225–1237.
   PubMed Web of Science ®Google Scholar
• Zhang N, Zhang W, Jin Y, Quan D. 2011. Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs. Pharm Dev Technol. 16(4):415–421.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhi Z, Jiang T, Zhang J, Wang Z, Wang S. 2010. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release. 145(3):257–263.
   PubMed Web of Science ®Google Scholar